Taxonomy Viewer

RJ 655 - Healthcare institutions

Browse through 12,486,109 XBRL objects!

Taxonomy Viewer

Statistics

XBRL Model Project

Arc name	presentationArc
Arc role	http://www.xbrl.org/2003/arcrole/parent-child
Link role	urn:rj:linkrole:annual-reporting-guidelines-655

Concept	Order
RJ 655 - Healthcare institutions `rj-abstr:AnnualReportingGuidelines655Title`
Related expenditures `rj-i:CentralGovernmentExpenditures`	1
Disclosure of costs of outsourcing and subcontracting `rj-i:CostsOfOutsourcingAndSubcontractingDisclosure`	2
Policy of costs of outsourcing and subcontracting `rj-i:CostsOfOutsourcingAndSubcontractingPolicy`	3
Costs of outsourcing and subcontracting `rj-i:CostsOfOutsourcingAndSubcontracting`	4
Disclosure of income from subcontracting `rj-i:IncomeFromSubcontractingDisclosure`	5
Policy of income from subcontracting `rj-i:IncomeFromSubcontractingPolicy`	6
Income from subcontracting `rj-i:IncomeFromSubcontracting`	7
Indication of whether the levy of the macro management instrument has been determined `rj-i:MacroControlInstrumentFinalDeterminationDescription`	8
Indication of whether a liability or provision is included in the balance sheet `rj-i:MacroControlInstrumentLiabilityOrProvisionDescription`	9
Reference to the available information on compliance with the codes of conduct `rj-i:ReferenceToTheAvailableInformationOnComplianceWithCodesOfConduct`	10
Description whether specific codes of conduct are mandatory or voluntary `rj-i:DescriptionWhetherSpecificCodesOfConductAreMandatoryOrVoluntary`	11
Description of specific codes of conduct are followed and which codes of conduct are concerned `rj-i:DescriptionSpecificCodesOfConductFollowedAndWhichCodesOfConductAreConcerned`	12
Description of the principal risks and uncertainties relating to carrying out self-tests `rj-i:DescriptionOfThePrincipalRisksAndUncertaintiesRelatingToCarryingOutSelfTests`	13
Description of the principal risks and uncertainties relating to special cost developments (eg expensive medicines) `rj-i:DescriptionOfThePrincipalRisksAndUncertaintiesRelatingToSpecialCostDevelopments`	14
Description of the principal risks and uncertainties relating to bed reduction in mental health care `rj-i:DescriptionOfThePrincipalRisksAndUncertaintiesRelatingToBedReductionInMentalHealthCare`	15
Description of the principal risks and uncertainties relating to developments in the macro framework `rj-i:DescriptionOfThePrincipalRisksAndUncertaintiesRelatingToDevelopmentsMacroFramework`	16
Description of the principal risks and uncertainties relating to revenue recognition `rj-i:DescriptionOfThePrincipalRisksAndUncertaintiesRelatingToRevenueRecognition`	17
Description of the principal risks and uncertainties relating to contracting of care and performance-related funding `rj-i:DescriptionOfThePrincipalRisksAndUncertaintiesRelatingToContractingCarePerfomanceRelatedFunding`	18
Description of the principal risks and uncertainties relating to property valuation including impairments `rj-i:DescriptionOfThePrincipalRisksAndUncertaintiesRelatingToPropertyValuationIncludingImpairments`	19
Difference in result in the separate and consolidated financial statements `jenv-bw2-i:ResultDifferenceSeparateConsolidatedFinancialStatements`	20
Social security contributions `jenv-bw2-i:SocialSecurityContributions`	21
Result in the consolidated financial statements `jenv-bw2-i:ResultConsolidatedFinancialStatements`	22
Result in the separate financial statements `jenv-bw2-i:ResultSeparateFinancialStatements`	23
Assets `jenv-bw2-i:Assets`	24
Non-current assets `jenv-bw2-i:AssetsNoncurrent`	25
Intangible assets `jenv-bw2-i:IntangibleAssets`	26
Property, plant and equipment `jenv-bw2-i:PropertyPlantEquipment`	27
Financial assets `jenv-bw2-i:FinancialAssets`	28
Current assets `jenv-bw2-i:AssetsCurrent`	29
Inventories `jenv-bw2-i:Inventories`	30
Gross DBCs and DBC-healthcare products in progress `rj-i:DBCsDBCHealthcareProductsInProgressGross`	31
Receivables relating to financing deficit `rj-i:ReceivablesFinancingDeficit`	32
Trade and other receivables `rj-i:TradeOtherReceivables`	33
Current securities `jenv-bw2-i:SecuritiesCurrent`	34
Cash and cash equivalents `jenv-bw2-i:CashAndCashEquivalents`	35
Equity and liabilities `jenv-bw2-i:EquityAndLiabilities`	36
Equity `jenv-bw2-i:Equity`	37
Foundation capital `rj-i:FoundationCapital`	38
Designated funds `rj-i:DesignatedFunds`	39
Designated reserves `rj-i:DesignatedReserves`	40
General and other reserves `rj-i:GeneralOtherReserves`	41
Provisions `jenv-bw2-i:Provisions`	42
Non-current liabilities `jenv-bw2-i:LiabilitiesNoncurrent`	43
Non-current liabilities `jenv-bw2-dm:LiabilitiesNoncurrentMember`	44
Current liabilities `jenv-bw2-i:LiabilitiesCurrent`	45
Current liabilities `jenv-bw2-dm:LiabilitiesCurrentMember`	46
Current liabilities relating to financing surplus `rj-i:LiabilitiesFinancingSurplusCurrent`	47
Other current liabilities `rj-i:LiabilitiesCurrentOther`	48
Operating income `jenv-bw2-i:OperatingIncome`	49
Subsidy income `rj-i:SubsidyIncome`	50
Revenues from care services, youth assistance and social support `rj-i:IncomeFromCareServicesAndSocialSupport`	51
Other operating income `jenv-bw2-i:OperatingIncomeOther`	52
Operating expenses `jenv-bw2-i:OperatingExpenses`	53
Amortisation of intangible assets and depreciation of property, plant and equipment `jenv-bw2-i:DepreciationPropertyPlantEquipmentAmortisationIntangibleAssets`	54
Impairment of non-current assets `rj-i:ImpairmentAssetsNoncurrent`	55
Impairment of non-current assets `rj-i:ImpairmentAssetsNoncurrentInIncomeStatement`	56
Expenses for fees of independent medical specialists `rj-i:ExpensesFeesIndependentMedicalSpecialists`	57
Other operating expenses `jenv-bw2-i:OperatingExpensesOther`	58
Operating result `jenv-bw2-i:OperatingResult`	59
Financial income and expenses `rj-i:FinancialIncomeExpenses`	60
Result `rj-i:Result`	61
DBCs and DBC-healthcare products in progress (assets) `rj-i:DBCsDBCHealthcareProductsInProgressAssets`	62
DBCs and DBC-healthcare products in progress (liabilities) `rj-i:DBCsDBCHealthcareProductsInProgressLiabilities`	63
Provision for DBCs and DBC-healthcare products in progress `rj-i:DBCsDBCHealthcareProductsInProgressProvision`	64
Advances received for DBCs and DBC-healthcare products in progress `rj-i:DBCsDBCHealthcareProductsInProgressBillings`	65
Net DBCs and DBC-healthcare products in progress `rj-i:DBCsDBCHealthcareProductsInProgressNet`	66
Equity `jenv-bw2-dm:EquityMember`	67
Foundation capital `rj-dm:FoundationCapitalMember`	68
Designated reserves `rj-dm:DesignatedReservesMember`	69
Designated funds `rj-dm:DesignatedFundsMember`	70
General and other reserves `rj-dm:GeneralOtherReservesMember`	71
Movement in equity during the period `jenv-bw2-i:EquityMovement`	72
Designated reserve `rj-i:DesignatedReserve`	73
Description of the amount and the specific purpose of the designated reserves, as well as the fact that the management has made this limitation `rj-i:DesignatedReserveDescription`	74
Designated fund `rj-i:DesignatedFund`	75
Description of the amount and specific purpose of the designated funds, the reason for this limitation and any other conditions imposed by third parties `rj-i:DesignatedFundDescription`	76
Group equity `jenv-bw2-i:EquityGroup`	77
Share in group equity not accrued to legal entity `jenv-bw2-i:NoncontrollingInterest`	78
Income health insurance act `rj-i:IncomeHealthInsuranceAct`	79
Income legal budget for acceptable costs Wlz `rj-i:IncomeLegalBudgetAcceptableCostsWlz`	80
Income Youth law `rj-i:IncomeYouthLaw`	81
Income WMO `rj-i:IncomeWMO`	82
Income Ministry of Securitty and Justice `rj-i:IncomeMinistryVenJ`	83
Income availability contributions Healthcare `rj-i:IncomeAvailabilityContributionsHealthcare`	84
Income from other care services `rj-i:IncomeCareServicesOther`	85
Subsidy income from central governments relating to Ministry of V&J `rj-i:SubsidyIncomeCentralGovernmentsMinistryVenJ`	86
Subsidy income from central governments relating to Ministry of VWS `rj-i:SubsidyIncomeCentralGovernmentsMinistryVWS`	87
Central government contributions relating to the workplace function and medical faculty of UMC's `rj-i:CentralGovernmentContributionsWorkplaceFunctionMedicalFacultyUMCs`	88
Other subsidy income from central governments `rj-i:SubsidyIncomeCentralGovernmentsOther`	89
Income availability contributions Education `rj-i:IncomeAvailabilityContributionsEducation`	90
Subsidy income relating to provinces and municipalities (excluding WMO and Youth law) `rj-i:SubsidyIncomeProvincesMunicipalitiesExcludingWMOYouthLaw`	91
Other subsidies, including wage cost subsidies and EU subsidies `rj-i:SubsidyIncomeOther`	92
Other services (including 2nd - 4th flow of UMCs for research) `rj-i:OperatingIncomeOtherServicesOther`	93
Other income (including compensation for loaned person and rental property) `rj-i:OperatingIncomeOtherIncomeOther`	94
Expenses of employee benefits `jenv-bw2-i:EmployeeBenefitsExpenses`	95
Wages `jenv-bw2-i:WagesSalaries`	96
Pension costs `jenv-bw2-i:PensionCosts`	97
Other expenses of employee benefits `rj-i:EmployeeBenefitsExpensesOther`	98
Expenses of employee benefits excluding external employees `rj-i:EmployeeBenefitsExpensesExcludingExternalEmployees`	99
Expenses of external employees `rj-i:ExternalEmployeesExpenses`	100
Amortisation of intangible assets `jenv-bw2-i:AmortisationIntangibleAssets`	101
Depreciation of property, plant and equipment `jenv-bw2-i:DepreciationPropertyPlantEquipment`	102
General expenses `rj-i:GeneralExpenses`	103
Food and hospitality expenses `rj-i:FoodAndHospitalityExpenses`	104
Patient and residents dependent expenses `rj-i:PatientAndResidentsDependentExpenses`	105
Maintenance and energy expenses `rj-i:MaintenanceAndEnergyExpenses`	106
Rental and leasing expenses `rj-i:RentalLeasingExpenses`	107
Additions to provisions `rj-i:AdditionsProvisions`	108
Interest income `rj-i:InterestIncome`	109
Share in results of participating interests `jenv-bw2-i:ShareInResultsParticipatingInterests`	110
Changes in the value of financial assets and of securities that are part of the current assets `jenv-bw2-i:ChangesValueFinancialAssetsSecurities`	111
Other income from financial assets and securities `rj-i:IncomeOtherFinancialAssetsSecurities`	112
Interest expenses `rj-i:InterestExpenses`	113
Financing deficit (surplus) to be settled in rates `rj-i:FinancingDeficitSurplusToBeSettledInRates`	114
Movement of financing deficit (surplus) to be settled in rates `rj-i:FinancingDeficitSurplusToBeSettledInRatesMovement`	115
Financing difference during the period of the financing deficit (surplus) to be settled in rates `rj-i:FinancingDeficitSurplusToBeSettledInRatesFinancingDifferenceDuringPeriod`	116
Corrections from previous years of the financing deficit (surplus) to be settled in rates `rj-i:FinancingDeficitSurplusToBeSettledInRatesCorrectionsPreviousYears`	117
Payments (receipts) of financing deficit (surplus) to be settled in rates `rj-i:FinancingDeficitSurplusToBeSettledInRatesPaymentsReceipts`	118
Stage of adoption of financing deficit/surplus to be settled in rates `rj-i:FinancingDeficitSurplusToBeSettledInRatesStageOfAdoption`	119
Debts due to financing surplus `rj-i:FinancingDeficitSurplusToBeSettledInRatesIncludedInLiabilitiesFinancingSurplus`	120
Receivables from financing deficit `rj-i:FinancingDeficitSurplusToBeSettledInRatesIncludedInReceivablesFinancingDeficit`	121
Legal budget for acceptable costs `rj-i:IncomeLegalBudgetAcceptableCosts`	122
Fees to cover the legal budget for acceptable costs `rj-i:FeesToCoverLegalBudgetAcceptableCosts`	123
Financing deficit surplus `rj-i:FinancingDeficitSurplus`	124
Amount constituting the basis for the levy under the macro-control instrument `rj-i:MacroControlInstrumentTaxableBasis`	125
Staffing level `rj-i:StaffingLevel`	126
Disclosure of staffing level `rj-i:StaffingLevelDisclosure`	127
Statement of the destination of the profit or the processing of the loss `jenv-bw2-i:ResultsAppropriationDisclosure`	128
Disclosure of joint ventures `rj-i:JointVenturesDisclosure`	129
Names and addresses of the other participants in the joint venture `rj-i:JointVenturesOtherPartiesDescription`	130
Description of the activities of the joint ventures `rj-i:JointVenturesActivitiesDescription`	131
Description of the administrative relations of the joint ventures `rj-i:JointVenturesAdministrativeRelationsDescription`	132
Description of the composition of the board and the supervisory body of the joint ventures `rj-i:JointVenturesCompositionManagementSupervisoryBodyDescription`	133
Description of the exemption of consolidation in connection with the application of Section 2:408 `jenv-bw2-i:ConsolidationExemptionDescription`	134
Equity in the separate financial statements `jenv-bw2-i:EquitySeparateFinancialStatements`	135
Equity in the consolidated financial statements `jenv-bw2-i:EquityConsolidatedFinancialStatements`	136
Difference in equity in the separate and consolidated financial statements `jenv-bw2-i:EquityDifferenceSeparateConsolidatedFinancialStatements`	137
Disclosure of differences in the equity and result between the separate and consolidated financial statements `jenv-bw2-i:DifferencesEquityResultSeparateConsolidatedFinancialStatementsDisclosure`	138
Disclosure of information on funding parameters that are important for the granting of the government grant from the Ministry of Education, Culture and Science over the reporting year `rj-i:CentralGovernmentContributionsWorkplaceFunctionMedicalFacultyUMCsDisclosure`	139
Statutory reserve nature description `rj-i:StatutoryReserveNatureDescription`	140